New hope for the development of Alzheimer's disease therapeutics from Qiagen!

New hope for the development of Alzheimer's disease therapeutics from Qiagen!

Molecular Diagnostics

August 30, 2018

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by two types of lesions in the brain: extracellular senile plaques consisting of APP-derived amyloid ß (Aß) peptide and intracellular neurofibrillary tangles build out of hyperphosphorylated microtubule-associated tau protein. 

One process that could contribute to memory loss in AD due to synapse loss and neuronal cell death is the intracellular caspase cleavage of the amyloid precursor protein (APP), producing APP delta C31 and C31.

This review focuses on a high-throughput screening of small molecules that inhibit the APP-C31 generating cleavage pathway as part of AD drug discovery.

Read the full story!

Choose the right ELISA kit with Abcam!

Choose the right ELISA kit with Abcam!

Molecular Diagnostics

Careful evaluation of assay performance is an important first step in choosing a new ELISA kit. In fact, when using an ELISA kit, you want specific, accurate, sensitive, and reproducible results. To be sure your kit can deliver this, it’s important to have access to the validation data.

 

 

April 04, 2019 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us